- Home
- HYLN vs CATX Comparison
HYLN vs CATX Comparison
Compare HYLN & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYLN
- CATX
- Stock Information
- Founded
- HYLN 2018
- CATX 1983
- Country
- HYLN United States
- CATX United States
- Employees
- HYLN N/A
- CATX N/A
- Industry
- HYLN Construction/Ag Equipment/Trucks
- CATX Medical/Dental Instruments
- Sector
- HYLN Consumer Discretionary
- CATX Health Care
- Exchange
- HYLN Nasdaq
- CATX Nasdaq
- Market Cap
- HYLN 279.7M
- CATX 239.0M
- IPO Year
- HYLN N/A
- CATX N/A
- Fundamental
- Price
- HYLN $1.64
- CATX $3.60
- Analyst Decision
- HYLN Hold
- CATX Strong Buy
- Analyst Count
- HYLN 1
- CATX 11
- Target Price
- HYLN $2.00
- CATX $12.90
- AVG Volume (30 Days)
- HYLN 954.1K
- CATX 712.3K
- Earning Date
- HYLN 08-12-2025
- CATX 08-13-2025
- Dividend Yield
- HYLN N/A
- CATX N/A
- EPS Growth
- HYLN N/A
- CATX N/A
- EPS
- HYLN N/A
- CATX N/A
- Revenue
- HYLN $3,513,000.00
- CATX $1,235,000.00
- Revenue This Year
- HYLN $575.94
- CATX N/A
- Revenue Next Year
- HYLN $255.00
- CATX $11.99
- P/E Ratio
- HYLN N/A
- CATX N/A
- Revenue Growth
- HYLN 3559.38
- CATX N/A
- 52 Week Low
- HYLN $1.11
- CATX $1.60
- 52 Week High
- HYLN $4.10
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- HYLN 55.12
- CATX 44.08
- Support Level
- HYLN $1.47
- CATX $3.66
- Resistance Level
- HYLN $1.69
- CATX $4.08
- Average True Range (ATR)
- HYLN 0.10
- CATX 0.26
- MACD
- HYLN 0.01
- CATX -0.04
- Stochastic Oscillator
- HYLN 77.42
- CATX 19.40
About HYLN Hyliion Holdings Corp.
Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.